Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Current Deferred Tax Assets: 2015-2022

Historic Current Deferred Tax Assets for HUTCHMED (China) (HCM) over the last 1 years, with Jun 2022 value amounting to $83,000.

  • HUTCHMED (China)'s Current Deferred Tax Assets was N/A to $83,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $83,000, marking a year-over-year change of. This contributed to the annual value of $180,000 for FY2019, which is N/A change from last year.
  • Per HUTCHMED (China)'s latest filing, its Current Deferred Tax Assets stood at $83,000 for Q2 2022, which was down 74.77% from $329,000 recorded in Q1 2021.
  • In the past 5 years, HUTCHMED (China)'s Current Deferred Tax Assets registered a high of $7.9 million during Q2 2020, and its lowest value of $83,000 during Q2 2022.
  • In the last 3 years, HUTCHMED (China)'s Current Deferred Tax Assets had a median value of $759,000 in 2020 and averaged $2.4 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Current Deferred Tax Assets climbed by 4.76% in 2020, and later plummeted by 72.33% in 2021.
  • Quarterly analysis of 4 years shows HUTCHMED (China)'s Current Deferred Tax Assets stood at $180,000 in 2019, then grew by 4.76% to $7.9 million in 2020, then slumped by 72.33% to $329,000 in 2021, then reached $83,000 in 2022.
  • Its Current Deferred Tax Assets was $83,000 in Q2 2022, compared to $329,000 in Q1 2021 and $7.9 million in Q2 2020.